The Journal of Heart and Lung Transplantation
Volume 26, Issue 9 , Pages 953-955 , September 2007

Chylothoraces After Lung Transplantation for Lymphangioleiomyomatosis: Review of the Literature and Utilization of a Pleurovenous Shunt

  • Richard D. Fremont, MD

      Affiliations

    • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
    • Corresponding Author InformationReprint requests: Richard D. Fremont, MD, Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, T1218 MCN, 1161 21st Avenue S, Nashville, TN 37232-2650. Telephone: 615-322-3412. Fax: 615-343-8780.
    • ,
  • Aaron P. Milstone, MD

      Affiliations

    • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
    • ,
  • Richard W. Light, MD

      Affiliations

    • Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
    • Disclosure: R.W.L. has previously owned stock in Denver Biomedical, and that he is currently a speaker for Cardinal Health.
    • ,
  • Mathew Ninan, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee.

Received 21 March 2007 ,Revised 4 June 2007 ,Accepted 3 July 2007.

References 

  1. Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis. Am J Pathol. 1975;79:348–382
  2. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27:1056–1065
  3. Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest. 2003;123:623–627
  4. Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med. 1996;335:1275–1280
  5. Doerr C, Miller DL, Ryu JH. Chylothorax. Semin Respir Crit Care Med. 2001;22:617–626
  6. Gupta D, Ross K, Piacentino V, et al. Use of a LaVeen pleuroperitoneal shunt for refractory high-volume chylothorax. Ann Thorac Surg. 2004;78:9–12
  7. Bittmann I, Rolf B, Amann G, Lohrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol. 2003;34:95–98
  8. Kpodonu J, Massad MG, Chaer RA, et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant. 2005;24:1247–1253
  9. Light RW. Pleural diseases. In: 4th ed.. Philadelphia PA: Lippincott Williams & Wilkins; 2001;p. 327–343
  10. Pechet TT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant. 2004;23:301–308
  11. Pollock AV. The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valve. Br J Surg. 1975;62:104–107
  12. Artemiou O, Marta GM, Klepetko W, Wolner E, Muller MR. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg. 2003;76:231–233
  13. Tanaka E, Matsumoto K, Shindo T, Taguchi Y. Implantation of a pleurovenous shunt for massive chylothorax in a patient with yellow nail syndrome. Thorax. 2005;60:254–255
  14. Roukema JA, Lobach HJ, van der Werken C. Ascites after pleuroperitoneal shunting. Cancer. 1990;66:675–676

PII: S1053-2498(07)00521-9

doi: 10.1016/j.healun.2007.07.008

The Journal of Heart and Lung Transplantation
Volume 26, Issue 9 , Pages 953-955 , September 2007

Article Tools

* Image Usage & Resolution